SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Renovis -- Ignore unavailable to you. Want to Upgrade?


To: James Kibler who wrote (3)2/6/2004 6:28:34 PM
From: Peter H. Proctor  Respond to of 9
 
Renovis Post-IPO Price Action

Interesting Post-IPO action for Renovis. Apparently, the "smart money" would not pay more than $12 per share in the initial IPO, below estimates of $13-15. Likely, they "knew something" about Renovis' patent problems.

These patent issues are no secret. E.g., they apparently caused the original investors to pull the plug on Centaur and then enabled Renovis to buy Centaur's intellectual property ("IP") really cheap. It is even in the prospectus, if you know where to look. And not just in the boiler plate. But far from "full disclosure".

Perceiving underpricing and not knowing the true reason, the market then bid the stock from $12 up to briefly over $17 in just two days.

This suggests that, without the IP problems known to "smart money", Renovis would likely have gone at the high end of estimates, like most other IPO's yesterday. Maybe even higher. But without these IP problems, Renovis would not have gotten such a deal from Centaur.

Still, too bad for Renovis that they missed out on this run-up. Had the IPO gone for $15, they would have collected an additional $16.5 million. If the IPO had gone for $16 ( RNVS closed today at $16.20 ), an additional $22 million.

Disclosure: Likely, my IP is one part ( but certainly not all ) of the "prior art" causing the IP problems. See nitrone.com for the details.



To: James Kibler who wrote (3)2/9/2004 6:58:06 PM
From: OverUnder  Read Replies (2) | Respond to of 9
 
Jim: I got an allocation of 400 shares. This is the first IPO I've participated in since the go-go days of 2000 and so far, I'm obviously pleased with the stock's performance. I'm not sure that the >100 = a Dog comment strictly applies anymore since there isn't as much hyped up demand. The market action early last week probably had much to do with the price coming out below the offering range.

As far as RNVS goes, I'm wishing I bought more on the aftermarket. Alleged Patent conflicts not-withstanding, I think this one has a lot of potential